A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada
Author(s) -
J. Paul Whelan,
James M. Bowen,
Natasha Burke,
Edward A. Woods,
Gary P. McIssac,
Robert Hopkins,
Daria O’Reilly,
Feng Xie,
S Sehatzadeh,
Leslie Levin,
Suja P. Mathew,
Lisa L. Patterson,
Ron Goeree,
JeanÉric Tarride
Publication year - 2013
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.477
H-Index - 38
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.180
Subject(s) - medicine , lower urinary tract symptoms , international prostate symptom score , urology , transurethral resection of the prostate , quality of life (healthcare) , prostate , adverse effect , randomized controlled trial , prospective cohort study , shim (computing) , surgery , erectile dysfunction , nursing , cancer
Photoselective vaporization of the prostate (PVP) is a bloodless, relatively painless alternative to transurethral resection of the prostate (TURP) for relief of lower urinary tract symptoms (LUTS) in benign prostatic hyperplasia (BPH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom